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Abstract:  Serum  albumin  is  one  of  the  most  widely  studied  proteins.  It  is  the  most 
abundant protein in plasma with a typical concentration of 5 g/100 mL and the principal 
transporter of fatty acids in plasma. While the crystal structures of human serum albumin 
(HSA)  free  and  in  complex  with  fatty  acids,  hemin,  and  local  anesthetics  have  been 
characterized, no crystallographic models are available on bovine serum albumin (BSA), 
presumably because of the poor diffraction power of existing hexagonal BSA crystals. 
Here, the crystallization and diffraction data of a new BSA crystal form, obtained by the 
hanging drop method using MPEG 5K as precipitating agent, are presented. The crystals 
belong to space group C2, with unit-cell parameters a = 216.45 Å, b = 44.72 Å, c = 140.18 Å, 
β = 114.5° . Dehydration was found to increase the diffraction limit of BSA crystals from 
~8 Å to 3.2 Å, probably by improving the packing of protein molecules in the crystal 
lattice. These results, together with a survey of more than 60 successful cases of protein 
crystal dehydration, confirm that it can be a useful procedure to be used in initial screening 
as a method of improving the diffraction limits of existing crystals. 
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1. Introduction  
Serum albumins are the major soluble protein constituents of the circulatory system and have many 
physiological functions [1–3]. The most important property of this group of proteins is to serve as 
transporters for a variety of endogenous and exogenous compounds including metabolites, drugs and 
other  biologically  active  substances,  mostly  through  the  formation  of  non-covalent  complexes  at 
specific binding sites [2]. Various investigations have studied the structure and properties of serum 
albumins and their interactions with small molecules or with other proteins  [2,4,5]. Bovine serum 
albumin (BSA) is one of the most extensively studied of this group of proteins, particularly because of 
its structural homology with human serum albumin (HSA). BSA is also frequently used as a model 
system  for  physical  chemistry  studies,  as  it  is  an  easily  available,  low  cost,  protein  with  unusual  
ligand-binding properties [5,6].  
BSA is composed of a single chain of 583 amino acid residues including 35 cysteines (forming a 
total of 17 disulfide bridges), which confer a high stability to the protein. The molecular weight for 
BSA, calculated from different techniques, ranges from 66,411 to 66,700 Da and “the best value” in 
solution is 66,500 Da [1]. Its secondary structure is constituted by 67% α-helix and its isoelectric point 
(pI) is reported in a pH range of 4.8 to 5.6 [6–8]. The structure and properties of BSA in solution are 
characterized by a versatile conformation that is a function of pH, ionic strength, and the presence  
of ions [9].  
The structure of BSA in aqueous solution has been extensively studied in the past by small-angle  
X-ray  scattering  [10],  quasi-elastic  light  scattering  [11],  hydrodynamic  techniques  [12],  neutron 
scattering [13] and 
1H NMR [14], but surprisingly its X-ray structure has not yet been solved. The 
main reason for this failure is that BSA crystals obtained up to now diffract to low resolution (the best 
diffraction obtained so far is 8 Å resolution) [15–17].  
Here we describe the crystallization and preliminary X-ray diffraction studies of a new crystal form 
of BSA with two molecules in the asymmetric unit. We found that dehydration significantly improves 
the X-ray diffraction quality of these crystals. Dehydration is a post-crystallization treatment that tries 
to overcome the problems of loose packing of molecules and large solvent content, which are typical 
of protein crystals and lead to low-resolution diffraction. This procedure has previously been reported 
to increase the diffraction limit of many protein crystals. For a comprehensive survey of dehydration 
protocols the reader is referred to specific reviews which address this topic [18,19]. In this article, we 
also include a careful literature search of examples of improvements in X-ray diffraction properties of 
protein crystals, in an attempt to draw some conclusion from this review.  Int. J. Mol. Sci. 2012, 13     
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2. Results and Discussion  
2.1. Crystallization of BSA 
In the past, BSA crystals have been grown by a vapor diffusion technique from 50 mM potassium 
phosphate  buffer,  pH  6.2,  52%  saturated  ammonium  sulphate  at  298  K  [15–17].  However,  these 
crystals, which belong to space group P6 with unit cell parameters a = b =148.24 Å, c = 356.70 Å and 
α = 90° , β = 90° , γ = 120° , only diffract at low resolution (8–10 Å) [15,16].  
Screening  using  polyethylene  glycol  of  different  molecular  weights  (2000–20,000  Da)  as 
precipitating agent revealed new conditions for the crystallization of BSA. In particular, thin, small and 
fragile crystals appeared within 7 days using 30 mg mL
−1 protein concentration with the hanging-drop 
method from crystallization conditions in which the reservoir solution contained 24% w/v MPEG 2K,  
0.1 M Tris HCl pH 8. The quality of the crystals was improved by fine-tuning the concentration of 
protein (10.0–60.0 mg mL
−1), changing the precipitants and their concentration, and evaluating the 
effect of divalent cations, such as CaCl2, ZnCl2, MgCl2. The best crystals (Figure 1a–e) were obtained 
from a crystallization solution containing 22–24% w/v MPEG 5K, 0.2M MgCl2, 0.1 M Tris HCl pH 
7.8, 8.0 and 8.2 and BSA at 20.0 mg mL
−1. Further optimizations of the crystallization conditions to 
grow larger and thicker crystals suitable for diffraction data collection at high resolution, using other 
methods (sitting drops or microbatch without oil [20]) failed. 
Figure  1.  Image  of  typical  bovine  serum  albumin  (BSA)  crystals  grown  by  vapour 
diffusion (a–e). Crystals obtained from a crystallization solution containing 22–24% w/v 
MPEG  5K,  0.2M  MgCl2,  0.1  M  Tris  HCl  pH  7.8  (a–c)  and  8  (d–e)  and  protein 
concentration of 20.0 mg mL
–1. 
     
(a)  (b)  (c) 
   
(d)  (e) Int. J. Mol. Sci. 2012, 13     
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Various cryosolutions (20% v/v glycerol, 300 mg mL
−1 trehalose, 300 mg mL
−1 saccharose) were 
prepared to examine their ability to cryoprotect the BSA crystals. Preliminary X-ray diffraction data 
collected at 100 K showed that even the best crystals (Figure 1a,b) were intrinsically disordered and 
that the largest ones diffracted at most to 8 Å resolution using glycerol as cryoprotectant. Application 
of an annealing protocol failed to improve the crystal diffraction quality. The latter method transiently 
returns the flash-cooled crystal to ambient temperature and has been shown to improve poor resolution 
and mosaicity, presumably caused by incorrect flash-cooling [21,22]. However, as reported in other 
cases [18,19,23–26], we found an increase in the diffraction power of BSA crystals by dehydration.  
A  number  of  different  trials  for  dehydrating  crystals  have  been  described  in  the  literature.  
A  comprehensive  survey  of  the  successfully  used  dehydration  procedures  is  reported  in  
Table 1 [18,19,24–85]. The dehydration process has been applied with success to crystals of proteins 
of various molecular  weights,  protein-protein  and protein-ligand complexes.  The resolution  of  the 
diffraction data collected from dehydrated crystals ranges from 1.1 Å to 4.5–5 Å, with resolution 
improvements that in some cases have been >10 Å; while the solvent content values range from 23% 
to 85%, with a decrease upon dehydration that generally has been <10%. The values of relative humidity 
in equilibrium with the solutions of the examined systems range from 74.3% to 99.5%. As expected, 
the best improvements in the X-ray diffraction power of protein crystals have been observed when the 
dehydration  process  has  been  applied  to  crystals  with  the  highest  solvent  contents.  Notably,  the 
analysis of the Table suggests that even small changes in solvent content and relative humidity can 
promote  favorable  lattice  rearrangements  that  dramatically  improve  the  diffraction  properties  of 
crystals,  as  recently  suggested  by  Russi  et  al.  [26].  These  findings  underline  the  importance  of 
reproducible and controlled crystal dehydration, such as that which can be obtained using modern 
devices  available  at  synchrotron  beamlines  [86–88].  The  data  also  confirm  that  at  the  start  of  a 
dehydration experiment, the relative humidity in equilibrium with the mother liquor is very often close 
to 100%, in agreement with recent data [89]. Int. J. Mol. Sci. 2012, 13  3786 
 
Table 1. Dehydration of protein crystals and effect on solvent content and diffraction resolution. 
Protein crystal  Reference  Crystal precipitant
a  Dehydrating agent  Dehydration treatment  Space 
group 
(SG) 
Solvent content 
b 
before 
(%) 
Solvent content 
b 
after 
(%) 
RH 
before 
(%) 
RH 
after 
(%) 
Resolution 
before(Å) 
Resoluti
on after 
(Å) 
BSA  This work  22% MPEG 5K  30% PEG 8K  Transfer to drop of dehydr soln, 
10 min 
C2  50-53  47  99.2  98.5  ~8 
e  3.2 
e 
DsbG  [24]  20% PEG 4K  30% PEG 4K  Transfer to drop of dehydr soln, 
hang over reservoir of dehydr 
soln,12h 
C2  ~90  53  99.3  98.4  ~10
e  2.0 
e 
1.7 
d 
FAD-indep ALS  [28]  6–8% PEG 8K  
6–9% EG 
Ppt  
30% PEG 600 
Hang over same dehydr soln,  
12 h+ cryocool 
C2  NR  52  NC  NC  2.9 
e  2.6 
e 
Xis–DNA
X1-X2  [29]  30% PEG 4K  35–40%  
PEG 4K 
Replacing both the well and hang-
drop solutions with dehydr soln 
P3121 or 
P3221 
NR  59  98.4  96.9–
97.7 
10 
d  2.6 
d 
 
Aldolase C  [30]  25% PEG 8K 
4% glucose 
25% PEG 8K 
4% glucose 
Replacing both the well and hang-
drop solutions with dehydr soln 
P1  NR  NR  NC  NC  NR  3.0 
e 
Aldolase B  [31]  1.8–2.2 M AS  
2% diaminooctane 
3.5 M AS   Replacing both the well and hang-
drop solutions with dehydr soln 
P21212  NR  NR  91.2–
93.0 
85.3  NR  2.7 
e 
Tom20 receptor  [32]  15% PEG 6K  25% PEG 6K  Replacing both the well and hang-
drop solutions with dehydr soln 
C2  NR  NR  99.6  99.0  3–8 
d  2.1 
d 
transamidosome  [33]  10% PEG 4K  30% PEG 400  
10% PEG 4K 
Replacing the reservoir solution 
with dehydr soln 
P212121 
to P21 
upon 
dehydr 
NR  65  99.8  <97.1  4.0 
d  3.0 
d 
X (or ADRP) 
domain of a variant 
of feline coronavirus 
[34]  2.6–2.8 M AS  2.6–2.8 M AS 
4-17% glycerol 
Replacing the reservoir solution 
with dehydr soln 12h 
P41212  NR  78  NC  NC  4.5 
e  3.1 
d 
SecDF  [35]  26% PEG 400  50% PEG 400  Replacing both the well and 
hanging-drop solutions with 
dehydr soln 
P43212  75  74  97.7  92.3  4.2 
d  3.7 
d 
DsbC-DsbDα  [36]  25% MPEG 5K  
5% glycerol 
40% MPEG 5K 
10% glycerol 
Air dehydrate 30 min + cryocool  P43212  55  41  NC  NC  7.0 
e  3.8 
e 
2.3 
d 
Pyruvate 
Dehydrogenase 
[37]  6% PEG 3K  Ppt 
35% glycerol 
Air dehydrate for 28 months, 
rehydrate in same soln, cryocool 
R32  NR  73  99.9  90.5  7.0 
d  4.2 
d 
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Table 1. Cont. 
Protein crystal  Reference  Crystal precipitant
a  Dehydrating agent  Dehydration treatment  Space 
group 
(SG) 
Solvent content
b 
before 
(%) 
Solvent content 
b 
after 
(%) 
RH 
before 
(%) 
RH 
after 
(%) 
Resolution 
before(Å) 
Resoluti
on after 
(Å) 
E. coli YbgL  [25]  0.8M sodium citrate  Ppt  
10% EG 
Annealing+air dehydrate (2 h)  C2  NR  57  NC  NC  ~12
e  2.6 
e 
1.8 
d 
E. coli YggV  [25]  35% AS  37.5% AS 
10% glycerol 
Annealing+air dehydrate (30 min)  P43212  NR  38  89.5  <88.6  ~12
e  2.6 
e 
2.0 
d 
3-Dehydro dehy  [25]  11% PEG 8K  Ppt  
10% glycerol 
Annealing+air dehydrate (15 min)  P21  NR  88  99.8  <97.9  ND  3.0 
d 
Rv2002 gene 
product 
[38]  20% PEG 3K  Ppt  
10% MPD 
Anneal + air dehydrate, 5 h  P312 1  NR  35  NC  NC  2.1 
d  1.8 
d 
Peptide deformylase  [39]  12% PEG 4K  20% PEG 4K 
10% PEG 400 
Anneal + air dehydrate, 30 min  P212121  NR  50  99.7  <99.3  2.0 
d  1.8 
d 
CLC Cl channel  [40]  22–32% Jeffamine  Ppt  Incub. in cryst. drop  
(5 months) 
P222  NR  NR  NC  NC  7.5 
d  4.0 
d 
Cytochrome ba3 
oxidase 
[41]  14–16%  PEG 2K  20% glycerol 
20% EG 
Incub. under oil 2–4 h/ 
air exp. 10 min 
P43212  NR  62  99.6-
99.5 
<93.2  4.0 
d  2.3 
d 
5-Aminolaevulinic 
acid dehydratase 
[42]  0.7 M  1,6-hexanediol    Air dehydrate, 30 min   P 42212  NR  41 or 61  NC  NC  NR  2.7 
d 
Pea chloroplast 
photosystem I 
[26]  26% PEG 4K    Controlled relative humidity 
device 
P21  NR  NR  99  97  6.0 
d  4.0 
d 
Phosphoglycerate 
kinase 
[26]  26% PEG 4K    Controlled relative humidity 
device 
P21212 
 
NR  NR  98.5  97.5  3.0 
d  1.8 
d 
Thioredoxin  [43]  10% PEG 1000    Controlled relative humidity 
device 
C2221  NR  NR  NR  NR  8.0 
d  2.9 
d 
F1-ATPase  [44]  14% PEG 6K    Controlled relative humidity 
device 
P212121 
 
NR  Reduction of 22%  99  90  NR 
 
1.9 
d 
Dipeptidyl peptidase 
IV 
[45]  20–22% PEG 2K    Controlled relative humidity 
device 
P1  NR  NR  96.5  86.5  ~10 
d  3.0 
d 
Human GzmB  [46]  36% PEG 8K    Controlled relative humidity 
device 
P212121 
 
NR  NR  90  85  NR  3.1 
d 
Tricorn  Interacting 
Factor F3  
[47]  18% PEG 2K    Controlled relative humidity 
device 
P3221  NR  NR  98  94  BD  2.3 
d Int. J. Mol. Sci. 2012, 13  3788 
 
 
Table 1. Cont. 
Protein crystal  Reference  Crystal precipitant
a  Dehydrating agent  Dehydration treatment  Space 
group 
(SG) 
Solvent content 
b 
before 
(%) 
Solvent content 
b 
after 
(%) 
RH 
before 
(%) 
RH 
after 
(%) 
Resolution 
before(Å) 
Resoluti
on after 
(Å) 
pMHC complexed 
with GTSGSPIADK 
[48]  1.2 M K2HPO4  
0.6 M NaH2PO4 
  Controlled relative humidity 
device 
C2  NR  70  94.5  93.5  ~7 
d  3.2 
d 
RFC–PCNA  [50]  15% PEG 3.4K  33% PEG 3.4K  Serial transfer into increasing 
PEG 3.4K, 2h 
P212121  58  52  99.6  98.0  5.0 
d  2.8 
d 
Penicillin G acylase  [51]  29% PEG 4K  36–70%  PEG 4K 
12–15% glycerol 
Transfer to drop of dehydr soln 
(5–30 s) 
P21  NR  46  98.5  <84.1  8.0 
e  2.2 
e 
Cytochrome ba3 
oxidase mutants 
[52]  6–7% PEG 2K  50% MPD,  
14% PEG 2K 
Transfer to drop of dehydr soln  P43212 
P41212 
NR  57–6  99.9  <99.6  2.6–3.0 
d  2.3–2.4 
d 
ApoA-IV  [53]  22–28%  PEG 3.4K  60% PEG 3.4K  Transfer to drop of dehydr 
soln,12h 
P6  64  59  99.3–
98.6 
90.8  3.5 
d  2.7 
d 
Plant photosystem I   [54]  0.5% PEG 400 
3–5% PEG 6K 
0.5% PEG 400  
40% PEG 6K 
Transfer to drop of dehydr soln, 1 
week 
P21  NR  NR  99.9  97.0  4.4 
d  3.4 
d 
Nectin-1-EC 
complex 
[55]  5% PEG 300  25% PEG 300  Transfer in var. steps to drop of 
dehydr soln 
P213  NR  NR  99.6  97.4  ~5 
d  2.8 
d 
NgR  [56]  3.7 M NaCl  4.5 M NaCl  Transfer to drop of dehydr soln  P3121  90  85  87.0  84.3  ~5 
d  3.2 
d 
Munc18c–syntaxin 
41–29 complex 
[57]  10–13%  
PEG 3.4K 
25-30%  
PEG 3.4K 
Transfer in var. steps to drop of 
dehydr soln 
P213  54  53  99.8–
99.7 
98.9–
98.4 
4.3 
e  3.7 
e 
HIV-RT:inhibitor  [58]  6% PEG 3.4K  46% PEG 3.4K  Serial transfer, 5% increments,  
3 days 
P212121  56  48  99.9  95.5  3.7 
e  2.2 
e 
Pp 1,2-CCD  [59]  14% PEG 8K  16–18%  PEG 8K 
20 % glycerol 
Transfer to drop of dehydr soln, 
30-60s 
P6122  NR  63  99.7  <95.3  8–10 
d  ~3.3 
d 
ecSecA  [60]  6–9% PEG 35K  2 M KCl  NR  P21  65  56  NC  NC  ~3.5 
d  2.0 
d 
MTCP-1  [61]  1.5 M AS  2.0 M AS  Soaked for 1–5 months  P6222  41  37  94.2  92.1  3.0 
e  2.0 
e 
Trehalose 
phosphorylase 
[27]  10% PEG 4K  18% PEG 4K  Various procedures  P212121  NR  60  99.8  99.5  ~7–8 
d  ~3–4 
d 
Glutaryl-7-
aminocephalosporanic 
acid acylase 
[62]  4% PEG 8K 
10–20%  PEG 4K 
30% PEG 8K  
20% glycerol 
 
Transfer to drop of dehydr soln  P212121  NR  NR  NC  NC  ~4 
d  1.6 
e 
 
   Int. J. Mol. Sci. 2012, 13  3789 
 
 
Table 1. Cont. 
Protein crystal  Reference  Crystal precipitant
a  Dehydrating agent  Dehydration treatment  Space 
group 
(SG) 
Solvent content
b 
before 
(%) 
Solvent content 
b 
after 
(%) 
RH 
before 
(%) 
RH 
after 
(%) 
Resolution 
before(Å) 
Resoluti
on after 
(Å) 
EIICGlc(1–412, 
K394A, M17T, 
K150E) 
[63]  32–35%  PEG 400 
 
>80% PEG 400  Transfer to drop of dehydr soln, 
48 h. 
P212121  NR  85  96.8–
96.2 
74.3  ~8 
d  4.5 
e 
MaoC-like 
dehydratase 
[64]  5% PEG 6K  12% PEG 6K  Transfer to drop of dehydr soln, 
30 min  
P212121  NR  NR  99.9  99.8  ND  1.9 
d 
Fatty acid 
synthase 
[65]  4–5% PEG 6K  23% PEG 6K  Transfer to drop of dehydr soln,  P212121 
to P21 
upon 
dehydr 
67  65  99.9  99.2  ~8 
d  ~5 
d 
Nur  [66]  5% PEG 6K,  
5% MPD 
15% PEG 6K,  
10% MPD 
Transfer to drop of dehydr soln, 
20 min 
P31  NR  65  99.9  <99.6  NR  2.4 
d 
Monoclinic 
lysozyme 
[67]  10% NaCl  Satd NaCl solution  Transfer to drop of dehydr soln, 
20 min 
P21  29  23  91.1  79.3  1.4 
e  1.1 
e 
His6-RepE– 
DNA1 
[68]  10% PEG 4K  12% PEG 4K  Transfer to drop of dehydr soln, 
36 h 
P21  NR  63  99.8  99.8  ~8 
d  3.1 
d 
Ferredoxin 
reductase 
[69]  16-18% PEG 10K  20% PEG 4K  Transfer to drop of dehydr soln, 
15min 
P32211  NR  53  99.6–
99.5 
99.3  NR  2.2 
d 
MHC HLA-DQ2 
complexed with 
gliadin peptides 
[70]  25% PEG 4K  30% PEG 4K  dehydrated in a capillary 
containing dehydr soln, 3 days 
I23  NR  40  98.9  98.4  ~9 
d  3.9 
e 
HCMV protease  [71]  16% PEG 4K  30% PEG 4K  
0.15 M Na2SO4 
Serial increase in reservoir conc, 
3–5 days 
P412121  58  56  99.6  <98.4  3.0 
e  2.5 
e 
2.0 
d 
Human STAT1  [72]  10–12%  PEG 400  10.5% PEG 400 
10–30% PEG 4K 
Transfer in var. steps to drop of 
dehydr soln 
P6122  NR  60  NC  NC  3.7 
e  3.0 
e 
Monoclinic 
lysozyme 
[73]  3% NaNO3  Satd K2CrO4 
solution 
Seal crystal in capillary, add plug 
of dehydr soln, for 15–20 h 
P21  33  22  NC  NC  2.5 
e  1.7 
e 
Tetragonal 
lysozyme 
[74]  0.48–0.75 M NaCl  Satd salt solutions  Seal crystal in capillary, add plug 
of dehydr soln, for days to weeks 
P43212  NR  NR  98.3–
97.3 
79.3  3.7 
d  1.6 
d 
MmeI in complex 
with DNA 
[75]  10% PEG 8K  20% PEG 4K  Changing the mother liquor for 
crystal growth 
P1  NR  NR  99.8  99.3  ~4 
d  2.6 
d Int. J. Mol. Sci. 2012, 13  3790 
 
 
Table 1. Cont. 
Protein crystal  Reference  Crystal precipitant
a  Dehydrating agent  Dehydration treatment  Space 
group 
(SG) 
Solvent content
b 
before 
(%) 
Solvent content 
b 
after 
(%) 
RH 
before 
(%) 
RH 
after 
(%) 
Resolution 
before(Å) 
Resoluti
on after 
(Å) 
XRCC4–XLF 
complex 
[76]  1.8 M TC  2.5 M AS  Transfer to 2.5 M AS 1 week + 
over 4 M AS, 5 days + 0.5 mM 
TB and 60% PEG 8000, 3 h  
C2  NR  NR  NC  NC  ~20 
d  3.9 
d 
lipase–foldase 
complex 
[77]  12% PEG 4K  30% PEG 8K  Transfer in var. steps to drop of 
dehydr soln 
P3121  62  60  99.8  98.5  ~15 
d  2.9 
d 
F1-ATPase   [78]  20% PEG 6K  20% PEG 6K  
20% PEG 400 
Serial transfer into dehydr soln   P212121  NR  62  NC  NC  6–8 
d  3.1 
d 
EF-Tu-Ts  [79]  20% PEG 4K  28%–40%, var 
PEGs 
Serial transfer, 5 min each  P212121  61  55  NC  NC  4.0 
e  2.7 
e 
NF-κB  
P52-DNA 
[80]  4–6% PEG 4K  Ppt  
30% PEG 400  
HA 
Serial transfer into dehydr soln   I212121  52  49  NC  NC  3.5 
d  2.0 
d 
CBL1  [81]  25% PEG 3.4K  7% MPEG 2K  
0.7 M Li2SO4 
Transfer to dehydr soln, 5 min  P21212  NR  54  NC  NC  NR  2.9 
d 
Cx26  [82]  16–18%  PEG 200  25–30% TEG   Serial transfer into increasing 
TEG, 1-2days 
C2  NR  NR  NC  NC  ~7 
d  3.5 
d 
Nacetylglucosamine
-1-phosphate 
Uridyltransferase 
[83]  1.8 M AS  2.0 M AS 
Na malonate  
5% glycerol 
Serial transfer into dehydr soln  I432  Very high 
solvent content 
82  93.0  <92.
1 
3.8 
e  3.4 
e 
SeMet YidC  [84]  22% PEG 3350  
10% EG 
30% PEG 3.4K 
5–15% PEG 400 
Serial transfer into dehydr soln  C2  50  47  NC  NC  3.5 
e  1.8 
e 
DENV 3 RdRp  [85]  0.5% MPEG 5K   Var dehydr soln 
i.e., 30% PEG 4K  
Var procedures  C2221  NR  59  NC  NC  ~20 
d  1.8 
d 
  AS, ammonium sulphate, BD, bad diffraction; Dehydr soln, dehydrating solution; EG, ethylene glycol; hang drop, hanging drop; HA, heavy atom;MPD, 2-methyl-2,4-pentanediol; MPEG, 
PEG monomethylether; ND, no diffraction, NR, not reported; PEG, polyethylene glycol; ppt, precipitant; satd, saturated; TC, triammonium citrate, TB, tantalum bromide; TEG, triethylene 
glycol; var, various. 
   
a Crystal precipitant information does not include details of buffers and other additives used in crystallization; 
b Solvent content was not always reported by authors. In some cases it has been 
calculated from information provided in the text of the paper; 
c Relative humidity (RH) values have been calculated using the online calculator available at http://go.esrf.eu/RH, as described 
by Bowler and co-workers [89]. Concentrations have been converted from w/v to w/w using: w/w = w/v density
−1, where density values are taken from literature [90,91]; 
d X-ray diffraction 
resolution at a synchrotron source; 
e X-ray diffraction resolution on a rotating anode source.  
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Various dehydration protocols have been used. The dehydration process traditionally consists of 
equilibrating the protein crystals over a reservoir with a higher percentage of precipitant [24,28–35]. 
The hanging drop containing the crystals is then allowed to dehydrate for 12 h to 3 days. The simplest 
implementation involves dehydration by air [25,36–42]. Good results have been also obtained when 
protein crystals are mounted in a specific and adjustable stream of humidified gas, where it is possible 
to control the relative humidity [26,43–48,86–88]. Finally, crystal dehydration can also be performed 
by transferring the crystals into a dehydrating solution, which is the  original mother liquor with a 
higher concentration of precipitant [24,27,50–70] or with a different dehydrating agent [49,71–85].  
In the present case, common cryoprotectants, various salts (for example malonate) and different 
molecular-weight PEGs were tested as possible dehydration agents, but ultimately the most successful 
experiment was obtained when crystals which were grown in 22–24% w/v MPEG 5K, 0.2 M MgCl2, 
0.1 M Tris HCl pH 7.8 were directly transferred to a solution containing 30% w/v PEG 8K, 0.1M 
MgCl2, 0.05 M Tris HCl pH 7.8. Crystals did not show any signs of cracking during dehydration. After 
dehydration and cryocooling, the diffraction resolution of the crystals on the in-house X-ray equipment 
improved to  3.24 Å  resolution.  The diffraction  resolution  could  be  even further improved  with  a 
synchrotron radiation source. Assuming the presence of two BSA molecules in the asymmetric unit, 
the crystal volume per unit molecular weight (VM) is 2.3 Å
3 Da
−1, with a solvent content of 47%, which 
is within the normal range for protein crystals [92]. The solvent content of the crystals was reduced by 
3-6% by dehydration. This process also produces a change in their relative humidity from 99.2%  
to 98.5%.  
The application of molecular replacement, as detailed in the Experimental Section, enabled the 
identification of orientation and position of the two molecules in the asymmetric unit that gave a 
satisfactory fit to the experimental data. Refinement of the model, obtained by molecular replacement 
using phases derived from the structure of HSA is in progress.  
The  structural  determination  will  provide  a  molecular  basis  for  explaining  numerous  physical 
phenomena and for future docking and molecular dynamics studies on BSA complexes with drugs and 
other bioactive small molecules.  
3. Experimental Section 
3.1. Crystallization of BSA 
Bovine serum albumin fraction V and all other reagents were purchased from Sigma Chemical Co. 
and used as supplied without further purification. BSA (80 mg/mL) was dissolved in 10 mM Tris-HCl 
buffer, pH 7.8. The protein concentration was determined spectrophotometrically using the extinction 
coefficient of 36,500 M
−1 cm
−1 at 280 nm [93].  
Crystallization trials were performed at 293 K by the hanging-drop or sitting drop vapor-diffusion 
methods with 0.5 μL of protein and 0.5 μL of precipitant solution and a reservoir volume of 500 μL or 
using the microbatch without oil method [20] with the same volumes. Initial screens have included 
systematic  PEG/pH  and  PEG/Ion  screens.  In  particular,  we  prepared  solutions  with  a  formulation 
similar to the commercially available kits of Hampton Research. More than 100 different conditions 
were examined. In these crystallization experiments we varied the concentration of PEG from 10% w/v Int. J. Mol. Sci. 2012, 13 
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to 30% w/v, the molecular weight of PEG from 2000 Da to 20,000 Da and the pH from 7 to 8. The 
effect of divalent cations, such as CaCl2, ZnCl2, MgCl2 was also evaluated. 
Needle crystals were obtained within 7 days from drops containing BSA (30 mg mL
−1 in 10 mM 
Tris-HCl, pH 7.4) 24% w/v MPEG 2K and 0.1 M Tris HCl pH 8. An improvement in the quality of 
crystals was obtained using different salts and precipitant agents. In particular, well shaped crystals 
were grown using 22% w/v MPEG 5K, 0.2 M MgCl2, 0.1 M Tris HCl pH 7.8 as a precipitant solution. 
These  crystals  diffracted  to  8  Å  resolution.  In  all  the  experiments,  standard  24-well  linbro  plates 
(Hampton Research, Laguna Niguel, USA) were used.  
3.2. Dehydration  
A significant improvement in the crystal diffraction quality was obtained by dehydration with PEG 
8K. In this procedure, protein crystals were transferred in a loop to a 5 μL solution containing 30% w/v 
PEG 8K, 0.05 M Tris HCl pH 7.8 and 0.1 M MgCl2 for 10 min in the open air. After dehydration, the 
crystals were cryoprotected by soaking for 5–10 s in a solution consisting of 30% w/v PEG 8K, 0.05 M 
Tris HCl pH 7.8 and 0.1 M MgCl2, 20% v/v glycerol and tested for diffraction quality as above.  
3.3. Data collection and Processing 
X-ray  diffraction  data  (3.24  Å  resolution)  were  collected  at  the  Institute  of  Biostructures  and 
Bioimages (Naples, Italy), at 100 K using a Rigaku MicroMax-007 HF generator producing Cu Kα 
radiation and equipped with a Saturn944 CCD detector. An oscillation range of 0.5°  and an exposure 
time of 55 s were adopted for the experiments. The data sets were indexed, processed and scaled using 
the HKL-2000 package (Table 2) [94].  
Table 2. Data collection statistics. 
Space group  C2 
Cell parameters 
a (Å) 
b (Å) 
c (Å) 
β (° ) 
 
216.45 
44.72 
140.18 
114.5 
Resolution limits (Å)  50.00–3.24 
Highest resolution shell (Å)  3.32–3.24 
No. of observations  57717 
No. of unique reflections  18006 
Completeness (%)  88.8 (81.5) 
I/σ (I)  5.5 (2.9) 
Average multiplicity  3.2 (2.4) 
Rmerge (%)  15.4 (31.9) 
Mosaicity  1.2 
Note: Values in parentheses correspond to the highest resolution shell. Int. J. Mol. Sci. 2012, 13 
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The overall Rmerge was high at 15.4% and the Rmerge value in the highest resolution bin was 31.9%. 
We attribute the high Rmerge value as being primarily due to the large number of weak reflections that 
were measured and maybe to some radiation damage.  
3.4. Structure Determination 
The structure of the protein was solved by molecular replacement using the program Phaser [95] 
and HSA as search model (PDB code 2AO6 [96]). Water molecules were removed from the model 
prior to structure factor and phase calculations. The solution had an R-factor of 0.39. 
4. Conclusions 
For  a  long  time  the  X-ray  structure  determination  of  BSA  has  been  prevented  due  to  the  low 
diffraction power of its crystals. In this study, new BSA crystals were grown, X-ray diffraction data 
collected and the phase problem solved. BSA crystals that were initially unacceptable for structural 
analysis improved in diffraction limit by a process of dehydration. The best BSA crystals diffracted  
X-rays to a maximum resolution of 3.24 Å. Our results will be useful for numerous scientists who 
study the interactions of serum albumin with ligands, a field of interest for a great variety of biological, 
pharmaceutical, toxicological and cosmetic systems.  
Our findings and previous literature results collected in Table 1 [18,19,24–85] confirm recent ideas 
that post-crystallization treatments can significantly improve X-ray diffraction protein crystal power. 
The analysis of the data does not enable us to define either a more promising dehydrating procedure or 
a more effective dehydrating agent. Rather, the review suggests that different procedures have to be 
tried, as the effects depend on both the protein nature and the crystal packing. Despite the high number 
of positive results, the technique remains little used. The  take-home message of this work is that 
dehydration  is  one  of  the  procedures  that  should  be  included  in  initial  screening  as  a  method  to 
improve or at least modify the diffraction properties of existing crystals. 
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